A Double-Blinded Placebo-Controlled Biomarker Stratified Randomized Trial of Apalutamide (APA) and Radiotherapy for Recurrent Prostate Cancer (NRG GU006, BALANCE trial)

01:00pm - 01:10pm PT

San Francisco Ballroom

Presenter(s)

Daniel Spratt, MD - University Hospitals Seidman Cancer Center, Case Western Reserve University, Beachwood, OH